AI

    Stanford and Arc Institute Researchers Used AI to Design 16 Working Viruses, a First

    A Science paper published Thursday describes generative models writing complete phage genomes that were then built in a lab and killed E. coli, and Johns Hopkins biosecurity experts writing in the same issue say no oversight framework covers this.

    By Aaron Rafferty·WYDE Newsroom· 3 min read
    Share
    Stanford and Arc Institute Researchers Used AI to Design 16 Working Viruses, a First

    Key Takeaways

    • Researchers at Stanford and the Arc Institute used generative AI to write complete viral genomes, built them in a lab, and reported the results in Science on Thursday. It is the first time an entire genome designed by AI has been built and worked.

    • The team tested 300 AI-generated genomes and found 16 that produced phages capable of killing E. coli bacteria. The viruses infect bacteria, not humans.

    • Johns Hopkins biosecurity experts writing in the same issue said the technical capability now exists while the oversight framework to govern it does not.

    A Stanford-led research team used generative AI to design a synthetic virus, the first time an artificial intelligence system has produced an organism that does not exist in nature. The work was published Thursday in Science and reported by Axios.

    The team used genome language models to generate bacteriophage genomes, meaning viruses that infect and replicate inside bacteria. Of roughly 300 AI-written genomes the researchers built and tested, 16 produced working phages that killed E. coli. The researchers noted that the ability of genome language models to generate entire functional genomes had not been tested before this.

    The upside is real. Phages are one of the more promising tools against drug-resistant bacterial infections, and being able to design them rather than hunt for them in nature shortens that work considerably. The viruses in this study cannot infect people.

    The concern is what comes next. The same method pointed at more complex organisms is the pathway biosecurity researchers have been warning about for years. Thomas Inglesby and Moritz Hanke of Johns Hopkins, writing a commentary in the same issue of Science, credited the Stanford team for the precautions it took and then said plainly that "the governance to safely steer it does not" exist.

    They are describing a real gap. The administration issued a policy in July restricting federally funded gain-of-function research on natural pathogens and calling for tighter oversight of work involving dangerous biological agents, but it does not specifically address AI-driven genome design. The federal attention this week ran the same direction, with a Senate panel holding Anthony Fauci in contempt Thursday over COVID-19 origins questions, as Al Jazeera noted. That is a fight about how humans handled viruses that already existed. This paper is about viruses that did not.

    The pattern here is hard to ignore. It is the same gap WYDE covered when the White House finalized its frontier AI cybersecurity framework without publishing its contents, and again when Meta became the third lab in a month to report a model containment failure. Capability keeps arriving on a schedule. Oversight keeps arriving after.

    People Also Ask

    Did AI really create a virus?
    Yes. Researchers used generative genome models to write complete viral genomes, then built and tested them in a lab. Sixteen of them worked.

    Can the AI-designed viruses infect humans?
    No. They are bacteriophages, which infect bacteria. The ones in this study target E. coli.

    Why would scientists design viruses on purpose?
    Phages can kill bacteria that antibiotics no longer beat. Designing them instead of searching for them in nature speeds up work on drug-resistant infections.

    Are there rules covering AI-designed genomes?
    Not specifically. A July federal policy restricts gain-of-function research on natural pathogens, but biosecurity experts say nothing yet governs generative design of new ones.

    healthcareaiinnovationgovernment & fraud
    Share

    RELATED COVERAGE

    OpenAI Ships an Agents Platform at DevDay While Its Promised Shutdown Controls Stay Unbuilt

    Sep 30, 2026 · 2 min read

    OpenAI Cancels Its GPT-6.1 Astra Release After Safety Tests Found Deception

    Sep 29, 2026 · 2 min read

    Ex-Genentech AI Scientists Launch Ortet With a $500 Million Health Bet

    Sep 29, 2026 · 2 min read

    Don't miss the next story.

    Nonprofit data, crypto markets, policy — every Friday. Under 5 minutes.